title: High expectation in non-evidence-based smoking cessation interventions among smokers--the CoLaus study.
abstract: OBJECTIVE
  To assess the preferred methods to quit smoking among current smokers.
  
  
  METHODS
  Cross-sectional, population-based study conducted in Lausanne between 2003 and 2006 including 988 current smokers. Preference was assessed by questionnaire. Evidence-based (EB) methods were nicotine replacement, bupropion, physician or group consultations; non-EB-based methods were acupuncture, hypnosis and autogenic training.
  
  
  RESULTS
  EB methods were frequently (physician consultation: 48%, 95% confidence interval (45-51); nicotine replacement therapy: 35% (32-38)) or rarely (bupropion and group consultations: 13% (11-15)) preferred by the participants. Non-EB methods were preferred by a third (acupuncture: 33% (30-36)), a quarter (hypnosis: 26% (23-29)) or a seventh (autogenic training: 13% (11-15)) of responders. On multivariate analysis, women preferred both EB and non-EB methods more frequently than men (odds ratio and 95% confidence interval: 1.46 (1.10-1.93) and 2.26 (1.72-2.96) for any EB and non-EB method, respectively). Preference for non-EB methods was higher among highly educated participants, while no such relationship was found for EB methods.
  
  
  CONCLUSIONS
  Many smokers are unaware of the full variety of methods to quit smoking. Better information regarding these methods is necessary.
authors.affiliation: Institute of Social and Preventive Medicine (IUMSP), University Hospital Center and Faculty of Biology and Medicine, Lausanne, 17 rue du Bugnon, 1005 Lausanne, Switzerland. Pedro-Manuel.Marques-Vidal@chuv.ch
authors.forename: Pedro
authors.initials: P
authors.lastname: Marques-Vidal
authors.forename: João
authors.initials: J
authors.lastname: Melich-Cerveira
authors.forename: Fred
authors.initials: F
authors.lastname: Paccaud
authors.forename: Gérard
authors.initials: G
authors.lastname: Waeber
authors.forename: Peter
authors.initials: P
authors.lastname: Vollenweider
authors.forename: Jacques
authors.initials: J
authors.lastname: Cornuz
mesh_terms: D015670:Acupuncture Therapy; D000328:Adult; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D000529:Complementary Therapies; D003430:Cross-Sectional Studies; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006990:Hypnosis; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000627:therapeutic use; D018722:Nicotinic Agonists / Q000627:therapeutic use; D057240:Patient Preference / Q000706:statistics & numerical data*; D012737:Sex Factors; D016540:Smoking Cessation / Q000379:methods*; D013557:Switzerland
chemical_list: D018687:Antidepressive Agents, Second-Generation; D018722:Nicotinic Agonists; D016642:Bupropion; D009538:Nicotine